Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous AmiodaroneSOMBERG, John C; TIMAR, Sandor; BRIDGES, Duane E et al.The American journal of cardiology. 2004, Vol 93, Num 5, pp 576-581, issn 0002-9149, 6 p.Article

Toxicité pulmonaire de l'amiodaroneBONNIAUD, P.Revue des maladies respiratoires. 2005, Vol 22, Num 5, pp 6S124-6S126, issn 0761-8425, CAH2Conference Paper

Amiodarone et thyroxineSWYNGHEDAUW, B.Archives des maladies du coeur et des vaisseaux. Pratique. 2010, Num 186, pp 36-37, issn 1261-694X, 2 p.Article

Amiodarone: an effective antiarrhythmic drug with unusual side effectsVAN ERVEN, Lieselot; SCHALIJ, Martin J.Heart (London 1996). 2010, Vol 96, Num 19, pp 1593-1600, issn 1355-6037, 8 p.Article

Frequency, Characteristics, and Risk Factors for Amiodarone NeurotoxicityORR, Carolyn F; AHLSKOG, J. Eric.Archives of neurology (Chicago). 2009, Vol 66, Num 7, pp 865-869, issn 0003-9942, 5 p.Article

The anomalous pharmacokinetics of amiodarone explained by nonexponential tissue trappingWEISS, M.Journal of pharmacokinetics and biopharmaceutics. 1999, Vol 27, Num 4, pp 383-396, issn 0090-466XArticle

Amiodarone induced skin necrosisRUSSELL, S. J; SALTISSI, S.Heart (London 1996). 2006, Vol 92, Num 10, pp 1395-1395, issn 1355-6037, 1 p.Article

Amiodarone et thyroïde : Endocrinologie = Amiodarone and thyroidMABY-MOTTET, V; OLLO, D; MEYER, P et al.Revue médicale suisse. 2012, Vol 8, Num 362, issn 1660-9379, 2175-2180 [5 p.]Article

Inhibition of the Type 2 lodothyronine Deiodinase Underlies the Elevated Plasma TSH Associated with Amiodarone TreatmentROSENE, Matthew L; WITTMANN, Gábor; ARROJO E DRIGO, Rafael et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 12, pp 5961-5970, issn 0013-7227, 10 p.Article

Nodular Amiodarone Lung DiseaseRUANGCHIRA-URAI, Ruchira; COLBY, Thomas V; KLEIN, Julianne et al.The American journal of surgical pathology. 2008, Vol 32, Num 11, pp 1654-1660, issn 0147-5185, 7 p.Article

Amiodarone-induced skin pigmentation : Q-switched laser therapy, an effective treatment optionWIPER, A; ROBERTS, D. H; SCHMITT, M et al.Heart (London 1996). 2007, Vol 93, Num 1, pp 15-15, issn 1355-6037, 1 p.Article

Absence of bilateral vision loss from amiodarone : A randomized trialMINDEL, Joel S; ANDERSON, Jill; JOHNSON, George et al.The American heart journal. 2007, Vol 153, Num 5, pp 837-842, issn 0002-8703, 6 p.Article

Amiodarone therapy for drug-refractory fetal tachycardiaSTRASBURGER, Janette F; CUNEO, Bettina F; PARILLA, Barbara V et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 3, pp 375-379, issn 0009-7322, 5 p.Article

Comparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus these not taking amiodaroneBLOMBERG, Patrick J; FEINGOLD, Andrew D; DENOFRIO, David et al.The American journal of cardiology. 2004, Vol 93, Num 3, pp 379-381, issn 0002-9149, 3 p.Article

Prévention des récidives d'hyperthyroïdie à l'amiodarone par l'iode = Prevention of recurrent amiodarone-induced hyperthyroidism by iodineHERMIDA, J. S; JARRY, G; TCHENG, E et al.Archives des maladies du coeur et des vaisseaux. 2004, Vol 97, Num 3, pp 207-213, issn 0003-9683, 7 p.Article

Clinical electrophysiologic effects of a single high oral dose of amiodaroneDEHARO, J. C; DURAND, A; MACALUSO, G et al.Fundamental & clinical pharmacology. 1997, Vol 11, Num 3, pp 275-280, issn 0767-3981Article

Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanismDI MATOLA, Tiziana; D'ASCOLI, Francesca; FENZI, Gianfranco et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 11, pp 4323-4330, issn 0021-972XArticle

A rare case of factor V inhibitor in a patient on amiodarone therapyVARNAM SHREENIVAS, Aditya; LIPSHITZ, Jay; PATEL, Dilip et al.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 4, pp 342-344, issn 0957-5235, 3 p.Article

Efficacy and Safety of Dofetilide in the Treatment of Frequent Ventricular Tachyarrhythmias After Amiodarone Intolerance or FailurePINTER, Arnold; AKHTARI, Shadi; O'CONNELL, Timothy et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 3, pp 380-381, issn 0735-1097, 2 p.Article

What could be expected after fifteen years of amiodarone therapy?RADMAN, Maja; TOMAS, Davor; SITUM, Mirna et al.EJD. European journal of dermatology. 2008, Vol 18, Num 2, pp 202-203, issn 1167-1122, 2 p.Article

Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 5'-monophosphate- and iodine- independent mechanismTEDELIND, S; LARSSON, F; JOHANSON, C et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 6, pp 2936-2943, issn 0013-7227, 8 p.Article

Amiodarone-induced alveolar hemorrhageISKANDAR, Said B; ABI-SALEH, Bernard; KEITH, Rob L et al.Southern medical journal (Birmingham). 2006, Vol 99, Num 4, pp 383-387, issn 0038-4348, 5 p.Article

Use of population modeling to define rational monitoring of amiodarone hepatic effectsPOLLAK, P. Timothy; SHAFER, Steven L.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 4, pp 342-351, issn 0009-9236, 10 p.Article

Of pills and pillows: Pseudopigmentation in a patient taking amiodaroneGUTKNECHT, David R.Cutis (New York, NY). 2000, Vol 66, Num 4, issn 0011-4162, p. 294Article

Amiodaron-Pigmentierung = Amiodarone-induced pigmentationSCHOLZ, S; ROMPEL, R.H + G. Zeitschrift für Hautkrankheiten. 1997, Vol 72, Num 12, pp 901-904, issn 0301-0481Conference Paper